Article
Instructive cross-talk between neural progenitor cells and gliomas.
Journal of neuroscience research - 1 Aug 2007
Staflin Karin, Lindvall Magnus, Zuchner Thole, Lundberg Cecilia
Abstract excerpt
Gliomas are the most common primary brain tumors and offer a poor prognosis in patients because of their infiltrative and treatment-resistant nature. The median survival time after diagnosis is approximately 11-12 months. There is a strong need for novel treatment modalities in targeting gliomas, and recent advances use neural progenitor cells as delivery systems for different therapeutic strategies. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
